+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Reproductive Genetics Market Analysis, 2021

  • PDF Icon

    Report

  • 254 Pages
  • July 2021
  • Region: Global
  • MarkNtel Advisors LLP
  • ID: 5439536
Reproductive Genetics is the branch of science that deals with the relationship between reproduction and genotype. It involves various tests and procedures to offer needful information about the probabilities of having a child in case of any specific genetic disorder. Moreover, Reproductive Genetics further help predict & prevent genetic disorders during reproductive procedures.

The “Global Reproductive Genetics Market” is likely to grow at a CAGR of around 12% during the forecast period, i.e., 2021-26, says the author. The market growth primarily attributes to molecular diagnostics and rising awareness regarding genetic testing & screenings. With technological advancements, genetic tests are gaining excellent popularity in reproductive procedures.

They assist in identifying the cause of infertility & carriers of inherited diseases, thereby helping in directing toward the most suitable assisted reproductive techniques. Hence, these factors are likely to fuel the Global Reproductive Genetics Market in the coming years


The research report, “Global Reproductive Genetics Market Analysis, 2021,” depicts a deep-dive market analysis of market statistics, including regional & country-wise market size, market forecast, CAGR & market share of different segments, competitive benchmarking, and key market drivers & restraints.

COVID-19 Outbreak Negatively Impacted the Global Reproductive Genetics Market


The outbreak of the COVID-19 pandemic has resulted in the governments of different nations enforcing strict movement restrictions and the shutdown of clinics. During this time, consumers shifted their preferences toward tele consulting to avoid the risk of getting infected.

Additionally, the shortage of skilled human resources, infrastructure, and logistic issues also affected the overall healthcare system. The situation worsened further due to reduced access & decline in genetic testing globally owing to the extended lockdown in all regions.

However, reproductive genetic testing companies incorporated several measures, including supply chain centralization, to recover from the losses caused by the pandemic. Hence, the market shall regain its usual pace and attain significant growth in the forecast period.

Market Segmentation


Career Screening Dominated the Global Reproductive Genetics Market with Largest Share


Based on the Procedure Type, the market bifurcates into Carrier Screening, Pre-Natal Screening, Pre-Implantation Genetic Testing, and Infertility Genetic Testing. Among these segments, Carrier Screening accounted for more than 50% of the market share in the previous few years and is likely to maintain its dominance over the forecast period.

Carrier Screening is a type of genetic test carried out on patients with a higher risk of passing on the genetic disorder to their children. The increased risk of genetic mutations and the wide-range utility of genetic testing at an early stage are the prime aspects that contributed to the adoption of Carrier Screening procedures.

Aneuploidy Captured the Significant Share of Global Reproductive Genetics Market


Based on the Application, the market divides into Aneuploidy, Structural Chromosomal Abnormality, and Single Gene Disorder. The Aneuploidy segment captured around 40% share of the Global Reproductive Genetics Market in the previous year. Most aneuploidies are considered lethal, claims experts. Additionally, their most common form is trisomy, present in 0.3% of all live births. Most cases of Aneuploidy result in miscarriage. Hence, the need for reproductive genetic consultation is significantly high in the cases of Aneuploidy, thereby propelling the overall market growth.

Regional Landscape


North America Attained the Highest Share of the Global Reproductive Genetics Market


Globally, North America acquired around 38% share of the Global Reproductive Genetics Market in the previous year. The U.S. remained the most dominating country in terms of revenue generation. Moreover, the presence of full-fledged operational units of conglomerate market players in the region is helping in the establishment of various start-up companies. Additionally, the several technological innovations of these players also propel the Global Reproductive Genetics Market.

Market Driver


Increasing Awareness and Acceptance for Genetic Testing and Screening


The growing literacy rate has led to a surge in the understanding levels regarding personal genomic risk, thereby impacting the public attitude and interest of the population globally. Furthermore, the rising public participation in personal genomics activities, including research and genomic services, has also fueled public awareness & understanding regarding genetics. Moreover, several educational programs run by the government and the emergence of direct-to-consumer (DTC) testing in the last few years have boosted the genomic healthcare knowledge among the population.

Market Challenge


Stringent Regulations & Norms to Restrain the Market Growth


Various regulatory bodies worldwide restrict the use of reproductive genetics tests as the subsequent rise in uptake of Pre-Natal testing is likely to surge the incidence of abortions. Therefore, professional organizations, such as the American College of Obstetricians and Gynecologists (ACOG), International Society for Pre-Natal Diagnosis, U.S. National Society of Genetic Counselors (NSGC), and the Japan Society of Obstetrics and Gynecology, have set up a few guidelines to limit the use of non-invasive Pre-Natal testing to pregnant women at high risk of chromosomal aneuploidies, thereby likely to hinder the overall market growth.

Competitive Landscape


According to the publishers, the leading industry players in the Global Reproductive Genetics market are ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd., Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, and QIAGEN NV.

Key Questions Answered in the Market Research Report:


1. What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global Reproductive Genetics Market?
2. What are the region-wise industry size, growth drivers, and challenges?
3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Reproductive Genetics Market?
4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Reproductive Genetics Market based on a competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the Global Reproductive Genetics Market study?

Table of Contents

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation
2. Preface3. Executive Summary4. Impact of COVID-19 on Global Reproductive Genetics Market
5. Global Reproductive Genetics Market Dynamics
5.1. Drivers
5.2. Challenges
6. Global Reproductive Genetics Market Hotspot & Opportunities7. Global Reproductive Genetics Market Trends & Developments8. Global Reproductive Genetics Research and Development Activities
9. Global Reproductive Genetics Market Regulations, By Region
9.1. The US
9.2. EU
9.3. Germany
9.4. France
9.5. The UK
9.6. China
9.7. Japan
9.8. South Korea
9.9. Others
10. Global Reproductive Genetics Market Intellectual Property Rights Analysis
10.1. Patents Filed YoY
11. Global Reproductive Genetics Market Outlook, 2018-2026F
11.1. Market Size & Analysis
11.1.1. By Revenues
11.2. Market Share & Analysis
11.2.1. By Procedure Type
11.2.1.1. Carrier Screening
11.2.1.2. Pre-Natal Screening
11.2.1.3. Pre-Implantation Genetic Testing
11.2.1.4. Infertility Genetic Testing
11.2.2. By Product Type
11.2.2.1. Kits
11.2.2.2. Laboratory Developed Tests
11.2.2.3. Reagents & Consumables
11.2.3. By Technology
11.2.3.1. Next Generation Sequencing
11.2.3.2. Polymerase Chain Reaction
11.2.3.3. In-Situ Hybridization
11.2.3.4. Microarray
11.2.4. By Application
11.2.4.1. Aneuploidy
11.2.4.2. Structural Chromosomal Abnormality
11.2.4.3. Single Gene Disorder
11.2.4.4. Others
11.2.5. By Region
11.2.5.1. North America
11.2.5.2. South America
11.2.5.3. Europe
11.2.5.4. Middle East & Africa
11.2.5.5. Asia Pacific
11.2.6. By Company
12. North America Reproductive Genetics Market Outlook, 2018-2026F
12.1. Market Size & Analysis
12.1.1. By Revenues
12.2. Market Share & Analysis
12.2.1. By Procedure Type
12.2.2. By Technology
12.2.3. By Country
12.2.3.1. The US Reproductive Genetics Market Outlook, 2018-2026F
12.2.3.1.1. Market Size & Analysis
12.2.3.1.1.1. By Revenues
12.2.3.1.2. Market Share & Analysis
12.2.3.1.2.1. By Procedure Type
12.2.3.2. Canada Reproductive Genetics Market Outlook, 2018-2026F
12.2.3.2.1. Market Size & Analysis
12.2.3.2.1.1. By Revenues
12.2.3.2.2. Market Share & Analysis
12.2.3.2.2.1. By Procedure Type
12.2.3.3. Mexico Reproductive Genetics Market Outlook, 2018-2026F
12.2.3.3.1. Market Size & Analysis
12.2.3.3.1.1. By Revenues
12.2.3.3.2. Market Share & Analysis
12.2.3.3.2.1. By Procedure Type
13. South America Reproductive Genetics Market Outlook, 2018-2026F
13.1. Market Size & Analysis
13.1.1. By Revenues
13.2. Market Share & Analysis
13.2.1. By Procedure Type
13.2.2. By Technology
13.2.3. By Country
13.2.3.1. Brazil Reproductive Genetics Market Outlook, 2018-2026F
13.2.3.1.1. Market Size & Analysis
13.2.3.1.1.1. By Revenues
13.2.3.1.2. Market Share & Analysis
13.2.3.1.2.1. By Procedure Type
14. Europe Reproductive Genetics Market Outlook, 2018-2026F
14.1. Market Size & Analysis
14.1.1. By Revenues
14.2. Market Share & Analysis
14.2.1. By Procedure Type
14.2.2. By Technology
14.2.3. By Country
14.2.3.1. Germany Reproductive Genetics Market Outlook, 2018-2026F
14.2.3.1.1. Market Size & Analysis
14.2.3.1.1.1. By Revenues
14.2.3.1.2. Market Share & Analysis
14.2.3.1.2.1. By Procedure Type
14.2.3.2. France Reproductive Genetics Market Outlook, 2018-2026F
14.2.3.2.1. Market Size & Analysis
14.2.3.2.1.1. By Revenues
14.2.3.2.2. Market Share & Analysis
14.2.3.2.2.1. By Procedure Type
14.2.3.3. The UK Reproductive Genetics Market Outlook, 2018-2026F
14.2.3.3.1. Market Size & Analysis
14.2.3.3.1.1. By Revenues
14.2.3.3.2. Market Share & Analysis
14.2.3.3.2.1. By Procedure Type
14.2.3.4. Spain Reproductive Genetics Market Outlook, 2018-2026F
14.2.3.4.1. Market Size & Analysis
14.2.3.4.1.1. By Revenues
14.2.3.4.2. Market Share & Analysis
14.2.3.4.2.1. By Procedure Type
14.2.3.5. Italy Reproductive Genetics Market Outlook, 2018-2026F
14.2.3.5.1. Market Size & Analysis
14.2.3.5.1.1. By Revenues
14.2.3.5.2. Market Share & Analysis
14.2.3.5.2.1. By Procedure Type
15. Middle East & Africa Reproductive Genetics Market Outlook, 2018-2026F
15.1. Market Size & Analysis
15.1.1. By Revenues
15.2. Market Share & Analysis
15.2.1. By Procedure Type
15.2.2. By Technology
16. Asia Pacific Reproductive Genetics Market Outlook, 2018-2026F
16.1. Market Size & Analysis
16.1.1. By Revenues
16.2. Market Share & Analysis
16.2.1. By Procedure Type
16.2.2. By Technology
16.2.3. By Country
16.2.3.1. China Reproductive Genetics Market Outlook, 2018-2026F
16.2.3.1.1. Market Size & Analysis
16.2.3.1.1.1. By Revenues
16.2.3.1.2. Market Share & Analysis
16.2.3.1.2.1. By Procedure Type
16.2.3.2. Japan Reproductive Genetics Market Outlook, 2018-2026F
16.2.3.2.1. Market Size & Analysis
16.2.3.2.1.1. By Revenues
16.2.3.2.2. Market Share & Analysis
16.2.3.2.2.1. By Procedure Type
16.2.3.3. India Reproductive Genetics Market Outlook, 2018-2026F
16.2.3.3.1. Market Size & Analysis
16.2.3.3.1.1. By Revenues
16.2.3.3.2. Market Share & Analysis
16.2.3.3.2.1. By Procedure Type
16.2.3.4. South Korea Reproductive Genetics Market Outlook, 2018-2026F
16.2.3.4.1. Market Size & Analysis
16.2.3.4.1.1. By Revenues
16.2.3.4.2. Market Share & Analysis
16.2.3.4.2.1. By Procedure Type
16.2.3.5. Australia Reproductive Genetics Market Outlook, 2018-2026F
16.2.3.5.1. Market Size & Analysis
16.2.3.5.1.1. By Revenues
16.2.3.5.2. Market Share & Analysis
16.2.3.5.2.1. By Procedure Type
17. Company Profiles
17.1. ThermoFisher Scientific
17.2. Eurofins Scientific SE
17.3. Natera Inc.
17.4. BGI Genomics
17.5. Illumina, Inc.
17.6. Agilent Technologies, Inc.
17.7. CENTOGENE AG
17.8. Fulgent Genetics, Inc.
17.9. F. Hoffmann-La Roche Ltd
17.10. Invitae Corporation
17.11. Laboratory Corporation of America Holdings
17.12. PerkinElmer, Inc.
17.13. Myriad Genetics, Inc.
17.14. OPKO Health, Inc.
17.15. Quest Diagnostics
17.16. QIAGEN NV
18. Disclaimer

Companies Mentioned

  • ThermoFisher Scientific
  • Eurofins Scientific SE
  • Natera Inc.
  • BGI Genomics
  • Illumina Inc.
  • Agilent Technologies Inc.
  • CENTOGENE AG
  • Fulgent Genetics Inc.
  • F. Hoffmann-La Roche Ltd
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • PerkinElmer Inc.
  • Myriad Genetics Inc.
  • OPKO Health Inc.
  • Quest Diagnostics
  • QIAGEN NV

Methodology

Loading
LOADING...